These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16917732)

  • 21. Construction of a survival tree for dependent censoring.
    Shimokawa A; Miyaoka E
    J Biopharm Stat; 2021 Jan; 31(1):63-78. PubMed ID: 32684123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint analysis of time-to-event and multiple binary indicators of latent classes.
    Larsen K
    Biometrics; 2004 Mar; 60(1):85-92. PubMed ID: 15032777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiparametric analysis of mixture regression models with competing risks data.
    Lu W; Peng L
    Lifetime Data Anal; 2008 Sep; 14(3):231-52. PubMed ID: 18193354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional tests in a competing risks model.
    Aldo S; Salmaso L; El Barmi H; Pesarin F
    Lifetime Data Anal; 2008 Jun; 14(2):154-66. PubMed ID: 17943442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semiparametric estimation in copula models for bivariate sequential survival times.
    Lawless JF; Yilmaz YE
    Biom J; 2011 Sep; 53(5):779-96. PubMed ID: 21887793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAISY: a new software tool to test global identifiability of biological and physiological systems.
    Bellu G; Saccomani MP; Audoly S; D'Angiò L
    Comput Methods Programs Biomed; 2007 Oct; 88(1):52-61. PubMed ID: 17707944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of affected risk factors on time to recurrence and death in patients with postoperative gastric cancer using copula function.
    Roshanaei G; Kazemnejad A; Sadighi S
    J Res Health Sci; 2014; 14(1):52-6. PubMed ID: 24402851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The analysis of failure times in the presence of competing risks.
    Prentice RL; Kalbfleisch JD; Peterson AV; Flournoy N; Farewell VT; Breslow NE
    Biometrics; 1978 Dec; 34(4):541-54. PubMed ID: 373811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the model-building strategy on inference about nonlinear and time-dependent covariate effects in survival analysis.
    Wynant W; Abrahamowicz M
    Stat Med; 2014 Aug; 33(19):3318-37. PubMed ID: 24757068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inference for the dependent competing risks model with masked causes of failure.
    Craiu RV; Reiser B
    Lifetime Data Anal; 2006 Mar; 12(1):21-33. PubMed ID: 16583297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalizations and applications of frailty models for survival and event data.
    Pickles A; Crouchley R
    Stat Methods Med Res; 1994; 3(3):263-78. PubMed ID: 7820295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flexible modeling of competing risks in survival analysis.
    Belot A; Abrahamowicz M; Remontet L; Giorgi R
    Stat Med; 2010 Oct; 29(23):2453-68. PubMed ID: 20645282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective impact of a covariate on competing failures with an example from a bone marrow transplantation study.
    Di Serio C
    Lifetime Data Anal; 1997; 3(2):99-122. PubMed ID: 9384617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nonidentifiability aspect of the problem of competing risks.
    Tsiatis A
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):20-2. PubMed ID: 1054494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual analysis in linear regression models with an interval-censored covariate.
    Topp R; Gómez G
    Stat Med; 2004 Nov; 23(21):3377-91. PubMed ID: 15490424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifiability of causal effects for binary variables with baseline data missing due to death.
    Yan W; Hu Y; Geng Z
    Biometrics; 2012 Mar; 68(1):121-8. PubMed ID: 21838813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
    Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
    N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.